ABBOTTLABORATORIES OFFICERSCERTIFICATE and COMPANYORDER February 5, 2004

EX-4.31 5 a2127912zex-4_31.htm EXHIBIT 4.31

Exhibit 4.31

 

ABBOTT LABORATORIES

 

OFFICERS’ CERTIFICATE

 

and

 

COMPANY ORDER

 

February 5, 2004

 

With respect to the issuance by Abbott Laboratories (the “Company”) of $500,000,000 in aggregate principal amount of 3.5% Notes due 2009 (the “Notes”), Jose M. de Lasa and Terrence C. Kearney, officers of the Company, certify pursuant to Sections 3.1 and 3.3 of the Indenture, dated as of February 9, 2001 (the “Indenture”), between the Company and J. P. Morgan Trust Company, N.A., successor in interest to Bank One Trust Company, N.A., as Trustee (the “Trustee”), as follows:

 

1.                                       We have read Sections 2.1, 3.1 and 3.3 of the Indenture and the definitions therein relating hereto, reviewed the resolutions of the Board of Directors of the Company adopted on September 12, 2003 (attached as Exhibit B to the Secretary’s Certificate of even date herewith), the Actions of the Authorized Officers of February 2, 2004 (attached as Exhibit C to the Secretary’s Certificate of even date herewith), conferred with executive officers of the Company and, in our opinion, made such other examinations and investigations as are necessary to enable us to express an informed opinion as to whether Sections 2.1, 3.1 and 3.3 of the Indenture have been complied with.

 

2.                                       Based on the above-described examinations and investigations, in our opinion, all conditions precedent relating to the authentication and delivery of the Notes, including those conditions under Sections 2.1, 3.1 and 3.3 of the Indenture, have been complied with.

 

3.                                       The terms of the Notes are set forth in the Actions of the Authorized Officers, dated February 2, 2004 (attached as Exhibit C to the Secretary’s Certificate of even date herewith).

 

4.                                       In accordance with the provisions of Section 3.3 of the Indenture, the Trustee is hereby authorized and requested to authenticate the Notes and to deliver such Notes to or at the direction of Banc of America Securities LLC, as representative of the several underwriters.

 

Capitalized terms used herein and not otherwise defined herein shall have the respective meanings assigned thereto in the Indenture.

 



 

IN WITNESS WHEREOF, the undersigned have executed this Officers’ Certificate as of the date first above written.

 

 

ABBOTT LABORATORIES

 

 

 

 

 

By:

/s/ Jose M. de Lasa

 

 

Name:

Jose M. de Lasa

 

Title:

Senior Vice President and
General Counsel

 

 

 

By:

/s/ Terrence C. Kearney

 

 

Name:

Terrence C. Kearney

 

Title:

Vice President and Treasurer